Job Recruitment Website - Zhaopincom - How about Enshi Yuanchang Pharmaceutical Co., Ltd.?

How about Enshi Yuanchang Pharmaceutical Co., Ltd.?

Enshi Yuanchang Pharmaceutical Co., Ltd. is a limited liability company (natural person investment or holding) registered and established in Enshi City, Enshi Tujia and Miao Autonomous Prefecture, Hubei Province on March 28, 2001. Its registered address is in Enshi, Hubei Province No. 998, Shizhou Avenue, City.

The unified social credit code/registration number of Enshi Yuanchang Pharmaceutical Co., Ltd. is 91422801726131667Y. The corporate legal person is Gao Qiong. The company is currently in business.

The business scope of Enshi Yuanchang Pharmaceutical Co., Ltd. is: retail of Chinese medicinal materials, Chinese patent medicines, Chinese medicine pieces, chemical preparations, antibiotic preparations, biochemical drugs, biological products, medical equipment; health food, chemical Reagents, fitness products, family planning drugs and supplies, disinfection supplies; wholesale and retail of cosmetics and daily necessities; wholesale of pre-packaged food; warehousing (limited to branch operations); parking services, house rentals; venue rentals; exhibition display services; moxibustion , acupuncture, massage, massage, cupping, traditional Chinese medicine beauty and body shaping, scraping, traditional Chinese medicine diagnosis and treatment. (Involving licensed business projects, you must obtain permission from relevant departments before operating). In Hubei Province, the total registered capital of companies with similar business scope is 2,360.71 million yuan, and the main capital is concentrated in 377 enterprises with a scale of more than 50 million and 1-10 million. Within this province, the current registered capital of enterprises is considered to be good.

Enshi Yuanchang Pharmaceutical Co., Ltd. has invested in 1 external company and has 104 branches.

View more information and information about Enshi Yuanchang Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.